お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
600255

世界の肥満外科手術用装置市場:市場規模、シェア、発展、成長率、需要予測

Obesity Surgery Devices Market by Procedure (Gastric Bypass, Sleeve Gastrectomy, Gastric Banding, BPD-DS, Non-Invasive Surgery), by Type, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

出版日: | 発行: Prescient & Strategic Intelligence Private Limited | ページ情報: 英文 139 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
世界の肥満外科手術用装置市場:市場規模、シェア、発展、成長率、需要予測
出版日: 2017年11月01日
発行: Prescient & Strategic Intelligence Private Limited
ページ情報: 英文 139 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の肥満外科手術用装置市場について調査分析し、市場規模と予測、地域別分析、競合情勢、企業プロファイルについて、体系的な情報を提供しています。

第1章 調査背景

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の市場規模と予測

  • 処置別
  • タイプ別
  • 地域別

第6章 北米の市場規模と予測

  • 処置別
  • タイプ別
  • 国別

第7章 欧州の市場規模と予測

  • 処置別
  • タイプ別
  • 国別

第8章 アジア太平洋地域の市場規模と予測

  • 処置別
  • タイプ別
  • 国別

第9章 ラテンアメリカの市場規模と予測

  • 処置別
  • タイプ別
  • 国別

第10章 中東・アフリカの市場規模と予測

  • 処置別
  • タイプ別
  • 国別

第11章 競合情勢

  • 主要企業の製品ベンチマーキング
  • 世界の主要企業の戦略的発展

第12章 企業プロファイル

  • Medtronic PLC
  • Johnson & Johnson
  • Spatz FGIA Inc.
  • W. L. Gore & Associates, Inc.
  • Apollo Endosurgery, Inc.
  • ReShape Lifesciences, Inc.
  • Intuitive Surgical, Inc.
  • Cousin Biotech

第13章 付録

目次
Product Code: LS10052

Global obesity surgery devices market size is forecasted to attain a value of $2.8 billion by 2023 growing at a CAGR of 9.9% during 2017-2023.

The boost in demand for the obesity surgery devices is due to various factors such as increasing prevalence of obesity leading to high demand for obesity surgeries, rising awareness about bariatric surgery in obese population, lifestyle changes leading to high risk of obesity, and technological advancements in the obesity surgery devices industry.

Insights on market segments

Minimally invasive and non-invasive surgeries are performed for treating obesity. The different minimally invasive surgeries performed are sleeve gastrectomy, gastric bypass, gastric banding, biliopancreatic diversion surgeries with a duodenal switch (BPD-DS) and several others. Sleeve gastrectomy surgery devices held the largest share in the obesity surgery devices market, since these surgeries result in more weight loss and have a low mortality rate, when compared to other alternative surgical procedures. The market for sleeve gastrectomy is expected to witness the fastest growth during the forecast period at a CAGR of 13.2%.

Obesity surgery is performed using several devices that are available in the market including stapling devices, gastric bands, gastric balloons, gastric electric stimulators and several others. Stapling devices held the largest share of the global obesity surgery devices market in 2016, owing to their high application in almost all types of bariatric surgeries to staple the stomach and intestine parts.

Asia-Pacific stands as the fastest growing market for obesity surgery devices

Asia-Pacific is expected to observe the fastest growth in the obesity surgery devices market, due to increasing aging population, rising prevalence of obesity, and booming medical tourism in the region. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the number of people aged 65 years and above constituted approximately 11.4% of population in 2013, and the count is estimated to reach approximately 20% of the population, by 2050. As a result, an increase in the demand for devices for obesity surgery is expected to increase in the region.

Also, according to the Organization for Economic Co-operation and Development (OECD), there is a steady increase in the obesity rate until 2030. Obesity rates are projected to increase at a faster pace in Korea where rates have been historically low. This is thus increasing the demand for products in the obesity surgery devices market.

Key competitors in the market are launching new and innovative products to gain a larger share

Globally, the key players in the obesity surgery devices market are launching new products to gain a larger market share. For instance, in April 2017, Intuitive Surgical, Inc., announced that the company had received CE Mark approval in Europe for its da Vinci X Surgical system. This approval expanded the company's product portfolio and also provided surgeons and hospitals with advanced robotic assisted surgical technology at an affordable range.

In May 2016, Apollo Endosurgery, Inc., along with Zillion technologies Inc., announced the launch of ORBERA Coach platform that would provide telehealth monitoring of patients undergoing ORBERA Gastric Balloon procedure. ORBERA Coach is a telehealth aftercare program that allows patients to access exercise, nutrition, and other coaching resources via on demand interaction with registered dietitians trained on the ORBERA procedure during the 12 months following placement of the ORBERA gastric balloon. These developments are likely to add to the growth of the obesity surgery devices market.

Other key manufacturers operating in the obesity surgery devices industry include Medtronic plc, Johnson & Johnson, Spatz FGIA Inc., W. L. Gore & Associates, Inc., ReShape Lifesciences, Inc. (formerly EnteroMedics Inc.), and Cousin Biotech.

Table of Content

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Procedure
    • 1.3.2 Market Segmentation by Type
    • 1.3.3 Market Segmentation by Geography
    • 1.3.4 Analysis Period
    • 1.3.5 Market Data Reporting Unit
      • 1.3.5.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Procedure
      • 4.1.1.1 Minimally-invasive surgery
        • 4.1.1.1.1 Sleeve gastrectomy surgery(SGS)
        • 4.1.1.1.2 Gastric bypass surgery (GBS)
        • 4.1.1.1.3 Gastric banding surgery
        • 4.1.1.1.4 Biliopancreatic diversion surgeries with a duodenal switch (BPD-DS)
        • 4.1.1.1.5 Others
      • 4.1.1.2 Non-invasive surgeries
    • 4.1.2 By Type
      • 4.1.2.1 Stapling devices
      • 4.1.2.2 Gastric bands
      • 4.1.2.3 Gastric balloons
      • 4.1.2.4 Gastric electrical stimulators
      • 4.1.2.5 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trend
      • 4.2.1.1 Increasing demand for less invasive procedures and gastric electrical stimulation for obesity surgery
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing prevalence of obesity leading to high demand for obesity surgeries
      • 4.2.2.2 Rising awareness about bariatric surgery among obese population
      • 4.2.2.3 Lifestyle changes leading to high risk of obesity
      • 4.2.2.4 Technological advancements in the obesity surgery devices industry
      • 4.2.2.5 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 High cost of obesity surgery
      • 4.2.3.2 Risk of infection and other complications associated with obesity surgery
      • 4.2.3.3 Unsuitability of obesity surgery to certain patient populations
      • 4.2.3.4 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Favorable government initiatives for research programs aimed at obesity treatment
      • 4.2.4.2 Favorable insurance coverage for treatment of obesity
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Buyers
    • 4.3.2 Bargaining Power of Suppliers
    • 4.3.3 Intensity of Rivalry
    • 4.3.4 Threat of New Entrants
    • 4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

  • 5.1 By Procedure
    • 5.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
  • 5.2 By Type
  • 5.3 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Procedure
    • 6.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
  • 6.2 By Type
  • 6.3 By Country

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Procedure
    • 7.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
  • 7.2 By Type
  • 7.3 By Country

Chapter 8. Asia-Pacific Market Size and Forecast

  • 8.1 By Procedure
    • 8.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
  • 8.2 By Type
  • 8.3 By Country

Chapter 9. Latin America Market Size and Forecast

  • 9.1 By Procedure
    • 9.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
  • 9.2 By Type
  • 9.3 By Country

Chapter 10. Middle East & Africa (MEA) Market Size and Forecast

  • 10.1 By Procedure
    • 10.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
  • 10.2 By Type
  • 10.3 By Country

Chapter 11. Competitive Landscape

  • 11.1 Product Benchmarking of Key Players
  • 11.2 Global Strategic Developments of Key Players
    • 11.2.1 Product Launch/Approval
    • 11.2.2 Merger and Acquisition
    • 11.2.3 Others

Chapter 12. Company Profiles

  • 12.1 Medtronic PLC
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
    • 12.1.4 Strategic Growth Plans
  • 12.2 Johnson & Johnson
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
    • 12.2.4 Strategic Growth Plans
  • 12.3 Spatz FGIA Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Strategic Growth Plans
  • 12.4 W. L. Gore & Associates, Inc.
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Strategic Growth Plans
  • 12.5 Apollo Endosurgery, Inc.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
    • 12.5.4 Strategic Growth Plans
  • 12.6 ReShape Lifesciences, Inc.
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
    • 12.6.4 Strategic Growth Plans
  • 12.7 Intuitive Surgical, Inc.
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
    • 12.7.4 Strategic Growth Plans
  • 12.8 Cousin Biotech
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Strategic Growth Plans

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2016)
  • TABLE 5 GLOBAL OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2017 - 2023)
  • TABLE 6 GLOBAL MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 7 GLOBAL MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 8 GLOBAL OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 9 GLOBAL OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 10 GLOBAL OBESITY SURGERY DEVICES MARKET, BY REGION, $M (2013 - 2016)
  • TABLE 11 GLOBAL OBESITY SURGERY DEVICES MARKET, BY REGION, $M (2017 - 2023)
  • TABLE 12 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2016)
  • TABLE 13 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2017 - 2023)
  • TABLE 14 NORTH AMERICA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 15 NORTH AMERICA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 16 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 17 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 18 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2016)
  • TABLE 19 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2017 - 2023)
  • TABLE 20 EUROPE OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2016)
  • TABLE 21 EUROPE OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2017 - 2023)
  • TABLE 22 EUROPE MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 23 EUROPE MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 24 EUROPE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 25 EUROPE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 26 EUROPE OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2016)
  • TABLE 27 EUROPE OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2017 - 2023)
  • TABLE 28 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2016)
  • TABLE 29 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2017 - 2023)
  • TABLE 30 ASIA-PACIFIC MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 31 ASIA-PACIFIC MINIMALLY INVASIVE SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 32 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 33 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 34 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2016)
  • TABLE 35 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2017 - 2023)
  • TABLE 36 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2016)
  • TABLE 37 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2017 - 2023)
  • TABLE 38 LATIN AMERICA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 39 LATIN AMERICA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 40 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 41 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 42 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2016)
  • TABLE 43 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2017 - 2023)
  • TABLE 44 MEA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2016)
  • TABLE 45 MEA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2017 - 2023)
  • TABLE 46 MEA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 47 MEA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 48 MEA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 49 MEA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 50 MEA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2016)
  • TABLE 51 MEA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2017 - 2023)
  • TABLE 52 MEDTRONIC PLC - AT A GLANCE
  • TABLE 53 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
  • TABLE 54 JOHNSON & JOHNSON - AT A GLANCE
  • TABLE 55 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY
  • TABLE 56 SPATZ FGIA INC. - AT A GLANCE
  • TABLE 57 W. L. GORE & ASSOCIATES, INC. - AT A GLANCE
  • TABLE 58 APOLLO ENDOSURGERY, INC. - AT A GLANCE
  • TABLE 59 APOLLO ENDOSURGERY, INC. - KEY FINANCIAL SUMMARY
  • TABLE 60 RESHAPE LIFESCIENCES, INC. - AT A GLANCE
  • TABLE 61 ENTEROMEDICS INC. - KEY FINANCIAL SUMMARY
  • TABLE 62 INTUITIVE SURGICAL, INC. - AT A GLANCE
  • TABLE 63 INTUITIVE SURGICAL, INC. - KEY FINANCIAL SUMMARY
  • TABLE 64 COUSIN BIOTECH - AT A GLANCE
  • List of Figures
  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL OBESITY SUREGERY DEVICES MARKET SUMMARY
  • FIG 9 PORTER'S FIVE FORCES ANALYSIS
  • FIG 10 GLOBAL OBESITY SURGERY DEVICES MARKET SNAPSHOT, BY PROCEDURE (2016)
  • FIG 11 GLOBAL OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2023)
  • FIG 12 GLOBAL MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 13 GLOBAL OBESITY SURGERY DEVICES MARKET SPLIT, BY TYPE (2016, 2023)
  • FIG 14 GLOBAL OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 15 WORLDWIDE MAJOR MARKETS FOR OBESITY SURGERY DEVICES
  • FIG 16 NORTH AMERICA OBESITY SURGERY DEVICES MARKET SNAPSHOT
  • FIG 17 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2023)
  • FIG 18 NORTH AMERICA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 19 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 20 NORTH AMERICA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2023)
  • FIG 21 EUROPE OBESITY SURGERY DEVICES MARKET SNAPSHOT
  • FIG 22 EUROPE OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2023)
  • FIG 23 EUROPE MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 24 EUROPE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 25 EUROPE OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2023)
  • FIG 26 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SNAPSHOT
  • FIG 27 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2023)
  • FIG 28 ASIA-PACIFIC MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 29 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 30 ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2023)
  • FIG 31 LATIN AMERICA OBESITY SURGERY DEVICES MARKET SNAPSHOT
  • FIG 32 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2023)
  • FIG 33 LATIN AMERICA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 34 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 35 LATIN AMERICA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2023)
  • FIG 36 MEA OBESITY SURGERY DEVICES MARKET SNAPSHOT
  • FIG 37 MEA OBESITY SURGERY DEVICES MARKET, BY PROCEDURE, $M (2013 - 2023)
  • FIG 38 MEA MINIMALLY INVASIVE OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 39 MEA OBESITY SURGERY DEVICES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG 40 MEA OBESITY SURGERY DEVICES MARKET, BY COUNTRY, $M (2013 - 2023)
  • FIG 41 PRODUCT BENCHMARKING OF KEY PLAYERS IN THE GLOBAL OBESITY SURGERY DEVICES MARKET
  • FIG 42 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT (2016)
  • FIG 43 MEDTRONIC PLC - REVENUE SPLIT BY GEOGRAPHY (2016)
  • FIG 44 JOHNSON & JOHNSON - REVENUE SPLIT BY SEGMENT (2016)
  • FIG 45 JOHNSON & JOHNSON - REVENUE SPLIT BY GEOGRAPHY (2016)
  • FIG 46 APOLLO ENDOSURGERY, INC. - REVENUE SPLIT BY SEGMENT (2016)
  • FIG 47 APOLLO ENDOSURGERY, INC. - REVENUE SPLIT BY GEOGRAPHY (2016)
  • FIG 48 INTUITIVE SURGICAL, INC. - REVENUE SPLIT BY SEGMENT (2016)
  • FIG 49 INTUITIVE SURGICAL, INC. - REVENUE SPLIT BY GEOGRAPHY (2016)
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.